Brian Henick, MD, discussed plans to investigate agents targeting ULBP-2/5/6, antibody drug conjugates, and other novel therapies in lung cancer research.
Brian Henick, MD
Advertisement
Articles by Brian Henick, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Tazemetostat Withdrawn From Follicular Lymphoma, Sarcoma Markets
2
Treating Young Patients With Colorectal Cancer: Talking With a Surgeon
3
FDA Issues CRL for Retifanlimab/Chemotherapy in Metastatic NSCLC
4
Dismantling Barriers to Early Adoption of Bispecifics in Multiple Myeloma
5